: CX3CL1 RNA and protein expression is down-regulated in GBM. A) Relative mRNA expression levels of CX3CL1 in naïve brain, PDGFB-driven GBM tissue, sorted GBM cells and cultured GBM spheres driven from NiG mice (n=3 for all the groups). The mRNA levels were normalized to mRNA levels of β-actin. There was a significant decrease in CX3CL1 mRNA levels when GBM tissue, sorted GBM cells, and GBM spheres were compared to naïve brain (Dunnett's multiple comparison test, **** p<0.0001). B) Chemokine arrays were performed using 300µg protein from naïve brain, GBM tissue, freshly-FACS sorted GBM cells (based on RFP), and cultured GBM cells at passage 2. C) Quantification of relative protein expression of CX3CL1 identified from chemokine arrays. D) Bar graph of FKN RNA expression in non-tumor and in different types and grades of gliomas from REMBRANDT.
ALL: All glioma (n=454), ASTROC: Astrocytoma (n=148), GBM: Glioblastoma (n=228), MIXED: Mixed (n=11), NON_T: Non-tumor (n=28), OLIGOD: Oligodendroglioma (n=67). UNKNOWN (n=67). 
